Life science innovation that results in successful commercialization of new drugs, therapies, vaccines and technologies that have a value based impact on patient care is not for the faint of heart.
along with organizations like Southeast Life Sciences keeps the community connected for opportunity.
among others throughout the region help promising life science innovators fail fast or reach their next milestone in a capital efficient way.
are all present within easy reach for life science innovators of all shapes and sizes here.
From the Georgia Department of Economic Development, “The state’s research universities – which generate more than $2 billion a year in public and private R&D funding – work closely together. That’s largely because of the Georgia Research Alliance (GRA), which expands research lab capacity (in talent and technology). Since its founding in 1990, GRA has become the national model for university research collaboration and public-private investment.”
Further, “Georgia ranks 2nd in the nation for the share of its universities’ research that is funded by industry (10.6%), a reflection of the close ties between academic research and industrial innovation in Georgia. Home to the U.S. Centers for Disease Control and Prevention (CDC), American Cancer Society, and other major centers of health care research.”
Boston, San Diego, the Bay Area and other locales where life science innovation currently thrives is due in large part to their hefty pools of investors. While the Southeast has work to do to catch up in capital investments in the life sciences outside of health IT (where Atlanta leads), the volume of investors and the quantity of dollars being invested in the life sciences is growing and is likely to continue to do so.
Southeast Life Sciences envisions a world-class ecosystem for life sciences in the southeast. We cultivate, convene, and connect the Southeast entrepreneurial ecosystem to foster life science innovation and investment across the region.
We bring your next, de-risked investable opportunity
We introduce you to your investors and potential partners
We bring your next clients
We pair innovators and entrepreneurs with the right investment partners at all stages on the commercialization pathway, acquisition or exit. We provide easy access to qualified experts on life science innovation from concept to commercialization including business strategy, design and development, reimbursement, regulatory, intellectual property, marketing, preclinical and beyond.
Southeast Life Sciences Announces Award Winners and PitchRounds Winners for the first AdvanSE Life Sciences Conference. November 13, 2020 On the closing day of the first annual Southeast Life Sciences conference, the AdvanSE Life Sciences Conference, we want to congratulation the winners of our awards and PitchRounds. Southeast Life Sciences
Atandra and RCE will be presenting June 16 at 2:20 during the Southeast Life Sciences Virtual PitchRounds. When we spoke last year RCE CEO Atandra Burman told us, “Our goal in 2019 is clinical validation and submit to FDA this fall. As our pilots materialize towards key insights, we look
On Tuesday, April 13, Southeast Life Sciences convened a panel of industry leading medtech and life science investors to discuss how activities have shifted and what the mid-long term ramifications will mean to early stage innovators. Bob Crutchfield moderated the discussion including insights from: Gerry Brunk of Lumira Ventures, Joe
With Shyam Parekh, Ph.D., Director, Strategy & Business Development, Avanos Medical. Inc.. Shyam Parekh’s role, as part of the Avanos’s corporate strategy group is to support the senior leaders in their strategic alliances and technology acquisitions needs. In other words, this gentleman would play a leading role on the team